LA JOLLA PHARMACEUTICAL CO Inventory Write-down
LA JOLLA PHARMACEUTICAL CO reported Inventory Write-down of $850.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2022-08-15
- LA JOLLA PHARMACEUTICAL CO inventory write-down for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- LA JOLLA PHARMACEUTICAL CO inventory write-down for the quarter ending 2021-09-30 was $0.00.
- LA JOLLA PHARMACEUTICAL CO inventory write-down for the quarter ending 2021-06-30 was $0.00.
- LA JOLLA PHARMACEUTICAL CO inventory write-down for the quarter ending 2021-03-31 was $850.00K.
- LA JOLLA PHARMACEUTICAL CO inventory write-down for fiscal 2021 was $850.00K, a 65.42% decline from fiscal 2020.
- LA JOLLA PHARMACEUTICAL CO inventory write-down for fiscal 2020 was $2.46M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $0.00 derived: sum of 2 quarters · filed 2022-03-09 | $0.00 derived: sum of 3 quarters · filed 2022-08-15 | $850.00K 10-K · filed 2022-03-09 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-08-15 | $850.00K 10-Q · filed 2021-11-04 | $2.12M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $850.00K 10-Q · filed 2022-08-15 | $2.12M derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | $850.00K 10-Q · filed 2022-05-16 | $2.12M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $2.46M 10-K · filed 2022-03-09 | ||
| 2020-09-30 | $1.19M 10-Q · filed 2021-11-04 |